(Q35124987)

6 August 2017

1 reference

title

Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype (English)

1 reference

6 August 2017

1 reference

1 reference

Sweet RA

1

1 reference

6 August 2017

Nimgaonkar VL

2

1 reference

6 August 2017

Devlin B

3

1 reference

6 August 2017

Jeste DV

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://www.nature.com/articles/4001262.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.MP.4001262

https://www.nature.com/articles/4001262

1 January 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.MP.4001262

1 January 2024

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

383-392

1 reference

New frontiers in Alzheimer's disease genetics

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

A full genome scan for late onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Increased familial risk of the psychotic phenotype of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Identification of the phenotype in psychiatric genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

The Columbia University Scale for Psychopathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

The neurobehavioural rating scale: assessment of the behavioural sequelae of head injury by the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

The evaluation of behavioral disturbances in Alzheimer's disease: the utility of three rating scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Overview of depression and psychosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychotic symptoms and physically aggressive behavior in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychiatric symptoms in patients with dementia predict the later development of behavioural abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Predictors of disease course in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychotic symptoms in dementia and the rate of cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Risk of mortality and institutionalization in demented patients with delusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Measuring cognitive change in a cohort of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

The course of psychopathologic features in mild to moderate Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Neuropathologic and neurochemical correlates of psychosis in primary dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Familial influence on variation in age of onset and behavioural phenotype in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Hallucinations and associated factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Clinical variables associated with psychosis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Linkage analysis of Alzheimer disease with psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Factors associated with psychotic symptoms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychotic symptoms and apolipoprotein E genotypes in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

A general conditional-logistic model for affected-relative-pair linkage studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Mixture models for linkage analysis of affected sibling pairs and covariates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Unbiased methods for population-based association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Identification of Novel Genes in Late-Onset Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Neurobehaviors and psychotic symptoms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimerʼs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Psychiatric phenomena in Alzheimer's disease. II: Disorders of perception

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Predictors of progression in patients with AD and Lewy bodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

A SPECT study of delusions in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

Variance component methods for detecting complex trait loci

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001262

7 January 2021

The nature of psychotic symptoms in senile dementia of the Alzheimer type.

10

1 reference

https://api.crossref.org/works/10.1038/SJ.MP.4001262

1 January 2024

Identifiers

1 reference

6 August 2017

1 reference